About Us


Sanguine Impact Investment invests in critical infrastructure in selected emerging markets and developing economies, helping to fill gaps in capital markets to support inclusive growth and sustainable and resilient communities.


We see infrastructure as the catalyst to create enduring jobs, enable economic development, build sustainable communities, and provide innovative environmental solutions while producing commercial returns, in the true spirit of impact investing.


Our team of experienced in house developers and fund managers are equipped with a thorough understanding of and ability to successfully manage risk at each stage of a project from conception to operation. This allows Sanguine to take mid-stage development risk in projects and develop these into bankable projects while applying the International Finance Corporation’s Sustainability Framework and Environmental and Social Performance Standards.


Sanguine invests in selected emerging markets and developing economies in the Asia Pacific and Sub-Saharan Africa.

In Sub-Saharan Africa, Sanguine’s focus countries include Botswana, Cote d’Ivoire, Ethiopia, Ghana, Kenya and Senegal.

In the Asia Pacific, our focus countries include Indonesia, Malaysia, Philippines, Thailand, Vietnam, Cambodia, Laos, Mongolia, Nauru, Timor Leste, Papua New Guinea, Solomon Islands, Samoa, Fiji, Tonga, and Vanuatu.


Christopher Leach—Chairman

Christopher Leach has 30 years experience as an advisor and investment manager. He focuses on emerging markets in Sub-Saharan Africa and Asia Pacific.

His core skills include, but are not limited to, infrastructure investment, cross-border structuring, international tax, and governance.

He was a partner at Deloitte for the Japan desk, and was formerly Director of Business Development for Asia at Crowe Horwath Asia Pacific Advisory covering 29 countries.

Christopher is a licence holder with the Qatar Finance Centre Regulatory Authority in Doha.

He also holds the globally recognised title of Chartered Tax Advisor. He is a member of the Australian Taxation Institute and a member of the Australian Chamber of Commerce in Hong Kong.

Christopher has studied Business, Economics and Taxation at the University of New South Wales, Sydney Australia.


We established Sanguine Impact Investment in 2007 and began investment and development of sustainable infrastructure in emerging markets and developing economies in 2015.

In 2020, we completed the expansion of our geographic footprint to include the Asia Pacific region for impact investment and in early 2022 we will complete the acquisition of a portfolio of 6 mid-stage renewable development projects.

In 2022, we are expanding operations with offices and on the ground professional in Cambodia, Indonesia, Philippines, Singapore, Thailand, and Vietnam.